InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Neuphoria Therapeutics Inc.

NEUP Clue Score63
United States Fiscal year ends June CIK 0001191070
$3.36 +0.30% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.36 −82.32% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 23 Dec 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2020Revenue0.0Net income1.4EPS, diluted−0.01Fiscal year 2021Net income0.9 −35.0%EPS, diluted−0.01Fiscal year 2022Revenue0.3Net income0.9 +2.3%EPS, diluted−0.02Fiscal year 2023Revenue0.0 −91.6%Operating income−22.0Net income−21.4 −2,441.0%EPS, diluted−0.02Fiscal year 2024Operating income−17.9Net income−15.5EPS, diluted−18.62Fiscal year 2025Revenue15.6Operating income−1.1Net income−0.4EPS, diluted−0.23Fiscal year 2026Revenue1.2 −92.5%Operating income−16.5Net income−13.5EPS, diluted−3.06
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.0 n/a 0.3 0.0 n/a 15.6 1.2
Growth −91.6% −92.5%
Operating income n/a n/a n/a −22.0 −17.9 −1.1 −16.5
Net income 1.4 0.9 0.9 −21.4 −15.5 −0.4 −13.5
Growth −35.0% +2.3% −2,441.0%
EPS, diluted −0.01 −0.01 −0.02 −0.02 −18.62 −0.23 −3.06

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2020Net margin2,944.3%Free cash flow margin−8,381.3%Fiscal year 2021Fiscal year 2022Net margin346.5%Free cash flow margin−8,252.7%Fiscal year 2023Operating margin−99,709.6%Net margin−96,982.3%Fiscal year 2024Fiscal year 2025Operating margin−7.2%Net margin−2.4%Fiscal year 2026Operating margin−1,401.1%Net margin−1,145.7%
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin n/a n/a n/a −99,709.6% n/a −7.2% −1,401.1%
Net margin 2,944.3% n/a 346.5% −96,982.3% n/a −2.4% −1,145.7%
Free cash flow margin −8,381.3% n/a −8,252.7% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2020Operating cash flow−3.9Capital expenditure−0.0Free cash flow−3.9Fiscal year 2021Operating cash flow−7.5Capital expenditure−0.0Free cash flow−7.5Fiscal year 2022Operating cash flow−21.8Capital expenditure−0.0Free cash flow−21.8Fiscal year 2023Operating cash flow−14.6Fiscal year 2024Operating cash flow−14.7Fiscal year 2025Operating cash flow0.1Fiscal year 2026Operating cash flow−12.4
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −3.9 −7.5 −21.8 −14.6 −14.7 0.1 −12.4
Capital expenditure −0.0 −0.0 −0.0 n/a n/a n/a n/a
Free cash flow −3.9 −7.5 −21.8 n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2020Cash4.6Shareholders’ equity12.7Fiscal year 2021Cash28.5Shareholders’ equity47.6Fiscal year 2022Cash23.2Shareholders’ equity39.2Fiscal year 2023Cash12.1Shareholders’ equity22.0Fiscal year 2024Cash12.6Shareholders’ equity17.5Fiscal year 2025Cash14.2Shareholders’ equity19.0Fiscal year 2026Cash19.9Shareholders’ equity24.6
FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 4.6 28.5 23.2 12.1 12.6 14.2 19.9
Shareholders’ equity 12.7 47.6 39.2 22.0 17.5 19.0 24.6

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2020 30 Jun 2020 FY2021 30 Jun 2021 FY2022† 30 Jun 2022 FY2023 30 Jun 2023 FY2024† 30 Jun 2024 FY2025† 30 Jun 2025 FY2026† 30 Jun 2026
Revenue and profit
0.0 n/a 0.3 0.0 n/a 15.6 1.2
Growth −91.6% −92.5%
5.8 5.8 16.0 19.6 n/a n/a n/a
n/a n/a n/a 8.9 8.5 7.8 7.4
n/a n/a n/a −22.0 −17.9 −1.1 −16.5
Growth
−6.0 −8.9 −22.0 −21.5 −15.6 −0.8 −13.6
−0.2 −0.2 −0.2 −0.1 −0.1 −0.5 −0.1
1.4 0.9 0.9 −21.4 −15.5 −0.4 −13.5
Growth −35.0% +2.3% −2,441.0%
Per share
−0.01 −0.01 −0.02 −0.02 −18.62 −0.23 −3.06
−0.01 −0.01 −0.02 −0.02 −18.62 −0.23 −3.06
Growth
544.9 779.9 1,353 1,469 0.8 1.6 4.4
544.9 779.9 1,353 1,469 0.8 1.6 4.4
Growth +43.1% +73.5% +8.5% −99.9% +95.0% +170.9%

† The diluted share count jumps at 2022 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 7 years on file.